Institutional Repository UDD

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

Files in this item

This item appears in the following Collection(s)

Search DSpace


Browse

My Account